期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 52, 期 21, 页码 6606-6620出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm9007938
关键词
-
资金
- ANZ Charitable Trusts
- National Health and Medical Research Council of Australia
- Australian Research Council
Bis(thiosemicarbazonato) metal complexes (M-II(btsc)) have demonstrated potential neuroprotective activity in cell and animal models of Alzheimer's disease (AD). Metal complexes can activate the epidermal growth factor receptor (EGFR), leading to inhibition of amyloid peptide accumulation in neuronal cells. As glial cells also have an important role in modulating neuronal health and survival in AD, we examined the effect of M-II(btsc) on activity of EGFR in an astroglial cell line. Our findings reveal potent activation of glial EGFR by glyoxalbis(N(4)-methylthlosemicarbazonato)Cu-II] (Cu-II(gtsm)). Activation of EGFR by Cu-II(gtsm) involved phosphorylation of multiple tyrosine residues and was mediated by a cognate ligand-independent process involving M-II(btsc) inhibition of protein tyrosine phosphatase (PTP) activity. EGFR activation resulted in release of growth factors and cytokines with potential modulatory effects on neuronal function. These Studies provide ail important insight into the mechanism of action of a neuroprotective M-II(btsc) and provide it basis for future studies into this novel approach to AD therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据